Literature DB >> 7259596

Cryotherapy for precancerous melanosis (atypical melanocytic hyperplasia) of the conjunctiva.

S Brownstein, F A Jakobiec, R D Wilkinson, J Lombardo, W B Jackson.   

Abstract

Two patients with progressive, diffuse precancerous melanosis (intraepithelial atypical melanocytic hyperplasia or melanocytic dysplasia) of the conjunctiva were treated with cryotherapy. In one patient, the contiguous cutaneous portions of both eyelids were involved and received the same therapy; the extensive disease of the patient was managed by two cryotherapy sessions during a period of 21/2 months. The melanocytic process in both patients showed a good response to this therapy, which resulted in a slough of the superficial conjunctiva with reepithelialization from adjacent areas. Neither patients has shown recurrent disease in more than seven months of follow-up, although one patient had incomplete regression of the melanocytic condition in the perilimbal region, which was subsequently treated by an excisional biopsy. Serious complications occurred in one patient who had corneal and lenticular opacities; this patient had severe extensive disease for which exenteration was considered the only feasible alternative therapy to control the melanocytic proliferation disorder adequately. Less severe complications also developed, including trichiasis, ptosis, transient hypotony, and macular edema. In this article, we discuss the clinical and histologic features of acquired pigmentations of the conjunctiva, the criteria for their management, and the approaches to minimize the complications that we have encountered with cryotherapy.

Entities:  

Mesh:

Year:  1981        PMID: 7259596     DOI: 10.1001/archopht.1981.03930020098009

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  7 in total

1.  Primary acquired melanosis of the conjunctiva: experience with 311 eyes.

Authors:  Jerry A Shields; Carol L Shields; Arman Mashayekhi; Brian P Marr; Raquel Benavides; Archana Thangappan; Laura Phan; Ralph C Eagle
Journal:  Trans Am Ophthalmol Soc       Date:  2007

2.  Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.

Authors:  C L Shields
Journal:  Trans Am Ophthalmol Soc       Date:  2000

3.  A prognostic index for patients with malignant melanoma of the conjunctiva.

Authors:  F H Stefani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

4.  Clinical predictive factors for development of recurrence and metastasis in conjunctival melanoma: a review of 68 cases.

Authors:  P De Potter; C L Shields; J A Shields; H Menduke
Journal:  Br J Ophthalmol       Date:  1993-10       Impact factor: 4.638

Review 5.  The ultrastructure of conjunctival melanocytic tumors.

Authors:  F A Jakobiec
Journal:  Trans Am Ophthalmol Soc       Date:  1984

6.  Orbital exenteration in 95 cases of primary conjunctival malignant melanoma.

Authors:  A D Paridaens; A C McCartney; D C Minassian; J L Hungerford
Journal:  Br J Ophthalmol       Date:  1994-07       Impact factor: 4.638

7.  Case of Rapidly Expanding Conjunctival Malignant Melanoma Initially from Primary Acquired Melanosis Diagnosed 14 Years Earlier.

Authors:  Hironobu Jimura; Yuuki Mishima; Chie Sotozono; Akihide Watanabe; Jun Asai; Chiho Ohbayashi; Nahoko Ogata
Journal:  Int Med Case Rep J       Date:  2021-05-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.